Back to Trades
Kelly Michael Aaron
DirectorCIK 0001769668
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 4
- Active
- 2025–2026
Kelly Michael Aaron, Director, has filed 5 reports across 4 companies, totaling $5.1M in disclosed volume. Purchases and sales are approximately balanced. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jun 8 | PRME Prime Medicine, Inc. | Kelly Michael Aaron | Director | Other | $0 |
| Jun 3 | NEO NEOGENOMICS INC | Kelly Michael Aaron | Director | Other | $0 |
| May 14 | BOOM DMC Global Inc. | Kelly Michael Aaron | Director | Grant | $0 |
| Apr 27 | FOLD AMICUS THERAPEUTICS, INC. | Kelly Michael Aaron | Insider | Other | $0 |
| Aug 5 | PRME Prime Medicine, Inc. | Kelly Michael Aaron | Director | Other | $0 |
5 filings